University of Oxford

University / College


Location: Oxford, United Kingdom (GB) GB

ISNI: 0000000419368948

ROR: https://ror.org/052gg0110

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Quantification of Efficiency Losses Due to Mobile Ions in Perovskite Solar Cells via Fast Hysteresis Measurements (2022) Le Corre VM, Diekmann J, Peña‐Camargo F, Thiesbrummel J, Tokmoldin N, Gutierrez-Partida E, Peters KP, et al. Journal article Comprehensive Organometallic Chemistry IV: Volume 1-15 (2022) Parkin G, Meyer K, O’hare D Authored book CODE-EHR best-practice framework for the use of structured electronic health-care records in clinical research. (2022) Kotecha D, Asselbergs FW, Achenbach S, Anker SD, Atar D, Baigent C, Banerjee A, et al. Journal article, Review article CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research. (2022) Kotecha D, Asselbergs FW, Achenbach S, Anker SD, Atar D, Baigent C, Banerjee A, et al. Journal article Model code of conduct: protection of academic freedom and the academic community in the context of the internationalisation of the UK HE sector (2022) Heathershaw J, Chalcraft J, Chubb A, Fulda A, Hughes C, Kaczmarska K, Karran T, et al. Journal article The small-sized telescope of CTAO (2022) Tagliaferri G, Antonelli A, Arnesen T, Aschersleben J, Attinà P, Balbo M, Bang S, et al. Conference contribution PHASE SEPARATION IN SYSTEMS OF INTERACTING ACTIVE BROWNIAN PARTICLES (2022) Bruna M, Burger M, Esposito A, Schulz SM Journal article Introduction: Freedom of Religion or Belief as a Human Right (2022) Bielefeldt H, Pinto TA, Petersen MJ Journal article Genetic loci and prioritization of genes for kidney function decline derived from a meta-analysis of 62 longitudinal genome-wide association studies (2022) Gorski M, Rasheed H, Teumer A, Thomas LF, Graham SE, Sveinbjornsson G, Winkler TW, et al. Journal article A phase II, randomized, open-label, 52-week study of seladelpar in patients with primary biliary cholangitis (2022) Bowlus CL, Galambos MR, Aspinall RJ, Hirschfield GM, Jones DE, Dörffel Y, Gordon SC, et al. Journal article